🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This 💯👇🏻

Hema Now: Episode 18: Myeloma Genetics, CAR-T, and Emerging Immunotherapies emjreviews.com/hematology/pod…

The most profound paragraph in all of Schopenhauer, at least to me

If only!

The pin

Carl Jung once said something that made the room go silent in my mind.

Your brain is a lawyer, not a judge—it argues for what you already believe, not what’s true.

Happy to share our new work out today on Blood Journals Portfolio #Blood where we report CD38 loss as recurrent mechanisms of resistance to anti-CD38 antibody in multiple myeloma. Great collaboration between Memorial Sloan Kettering Cancer Center MSK Department of Medicine U Calgary Heidelberg Myeloma Mayo Clinic #mmsm #wgs

The one form of myeloma that still defies our understanding British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

Regardless of your leaning, highly interesting. Lots of derívate thoughts

Innovation is often incremental but still beneficial. Some might suffer the “me-too phobia.”

-5 Michelin stars … 🤢

Opening the MRD reports often is a source of great joy. The recent New York article about the great progress with CART, said “From no hope…”. I beg to disagree #mmsm

One of the most accomplished Latin American novelist was incredibly insightful regarding culture and philosophy. And he warns all to avoid the loss of core values, later becoming “idiocracy.”

Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Increible! Ese es el camino! Amazing! That´s the way to do it!

Our top highlights from @EHA 2025. Explore the latest updates from #EHA2025: t.ly/6uoHY #LARVOL #Hematology #CancerResearch #Oncology #CancerData #OncologyInsights | ONCO BRUNO | Amer Zeidan MBBS,MHS ‏عامر زيدان | Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 | Hemant S. Murthy MD

Exploring the depths of hypogammaglobulinemia in lymphoid malignancies: Pathophysiology, clinical implications, management options, and future directions. Our latest review on the management of this potentially critical complication and lead by Dr. A. Wonnaparhown (Mayo Clinic